Below are the top small-cap biotechnology stocks on the NYSE and the NASDAQ in terms of cash.
Dendreon Corp DNDN had $497.54 million in total cash and $573.82 million in total debt for the latest quarter.
ViroPharma Inc VPHM had $473.36 million in total cash and $155.46 million in total debt for the latest quarter.
Momenta Pharmaceuticals Inc MNTA had $382.26 million in total cash and no debt for the latest quarter.
Nektar Therapeutics NKTR had $382.11 million in total cash and $228.85 million in total debt for the latest quarter.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in